retatrutide type 2 diabetes phase 2 trial weight loss 2024 Retatrutide, an experimental weight-loss drug 💉 A triple-action once-weekly injection

Lower peaks mean lower maximal metabolic stress, potentially keeping cells above the ATP threshold where they fail

While this approach allowed us to include all available subjects, it limits interpretation of potential sex-specific effects

A substudy examining participants with metabolic-associated steatotic liver disease produced results that no pharmacological intervention had previously achieved

One is already approved and available in China

Regular check-ins with your prescribing provider should include honest conversations about your weight trends, quality of life on medication, and sustainability of your regimen

In a clinical trial, one-year dulaglutide treatment in individuals with chronic kidney disease (CKD) and T2D resulted in an increased estimated glomerular filtration rate compared to insulin glargine